LAUREN MATTHEWS: Open Payments
NPI 1477107274 · WHITE HOUSE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,911 in 106 payments from 23 companies in 2025. Trend: 2023 $1,332 · 2024 $1,320 · 2025 $1,911
Food & beverage: $1,911
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 16 | $323 |
| AstraZeneca Pharmaceuticals LP | 9 | $255 |
| PFIZER INC. | 15 | $239 |
| ABBVIE INC. | 17 | $187 |
| Lilly USA, LLC | 14 | $148 |
| Corcept Therapeutics | 4 | $101 |
| Astellas Pharma US Inc | 4 | $89 |
| Otsuka America Pharmaceutical, Inc. | 4 | $81 |
| Axsome Therapeutics, Inc. | 2 | $65 |
| Amgen Inc. | 4 | $61 |
Products named: FARXIGA, NURTEC ODT, Ozempic, UBRELVY, Korlym, Veozah, Wegovy, REXULTI.
Industry payments across TN — which companies pay providers there.
